CYTX : Analysis & Opinions

  1. Australian Approval for Vertex' Kalydeco - Analyst Blog

    July 10, 2013
    Kalydeco sales should benefit from reimbursement in additional European countries and launch in new markets.
  2. New Data on Biogen's Eloctate - Analyst Blog

    July 8, 2013
    Eloctate is currently under FDA review.
Investing News
  1. Thoughts From The Frontline: Every Central Bank For Itself

    Thoughts from the Frontline: Every Central Bank for Itself
  2. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  3. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  4. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  5. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  6. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
Trading Center